Research graph
References from Mitochondria under the spotlight: On the implications of mitochondrial dysfunction and its connectivity to neuropsychiatric disorders. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41380-018-0125-2
10.1038/s41380-018-0125-2 · External reference
10.1016/j.tins.2008.04.001
10.1016/j.tins.2008.04.001 · External reference
Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice
10.1186/gm546 · 2014 · External reference
Mental disorders as networks of problems: a review of recent insights
10.1007/s00127-016-1319-z · 2017 · External reference
Epigenetic regulations in neuropsychiatric disorders
10.3389/fgene.2019.00268 · 2019 · External reference
10.1038/s41386-020-0648-5
10.1038/s41386-020-0648-5 · External reference
10.1016/j.neuron.2017.09.055
10.1016/j.neuron.2017.09.055 · External reference
10.1038/s41398-019-0643-y
10.1038/s41398-019-0643-y · External reference
10.1038/nrn3156
10.1038/nrn3156 · External reference
10.1080/14789450.2020.1723419
10.1080/14789450.2020.1723419 · External reference
10.1074/jbc.m115.699447
10.1074/jbc.m115.699447 · External reference
10.1038/mp.2008.22
10.1038/mp.2008.22 · External reference
The key roles of GSK-3beta in regulating mitochondrial activity
10.1159/000485580 · 2017 · External reference
LiCl regulates mitochondrial biogenesis during megakaryocyte development
10.1016/j.jtemb.2016.10.003 · 2017 · External reference
Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions
10.2174/1389450110607011421 · 2006 · External reference
Unresolved reference
External reference
Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders
10.1038/sj.mp.4001437 · 2004 · External reference
Are bipolar disorder and schizophrenia neuroanatomically distinct? an anatomical likelihood meta-analysis
2010 · External reference
10.1016/j.ijdevneu.2010.08.007
10.1016/j.ijdevneu.2010.08.007 · External reference
10.1016/j.biopsych.2017.09.010
10.1016/j.biopsych.2017.09.010 · External reference
10.3389/fnins.2018.00386
10.3389/fnins.2018.00386 · External reference
10.1038/mp.2010.136
10.1038/mp.2010.136 · External reference
10.1016/j.schres.2017.02.025
10.1016/j.schres.2017.02.025 · External reference
10.1016/j.neuroscience.2017.09.049
10.1016/j.neuroscience.2017.09.049 · External reference
Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder
10.3109/15622975.2012.662282 · 2014 · External reference
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis
2018 · External reference
Treatment with olanzapine, fluoxetine and olanzapine/fluoxetine alters citrate synthase activity in rat brain
10.1016/j.neulet.2010.10.037 · 2011 · External reference
Olanzapine plus fluoxetine treatment alters mitochondrial respiratory chain activity in the rat brain
10.1111/j.1601-5215.2011.00569.x · 2011 · External reference
Brain region- and sex-specific modulation of mitochondrial glucocorticoid receptor phosphorylation in fluoxetine treated stressed rats: effects on energy metabolism
10.1016/j.psyneuen.2013.07.019 · 2013 · External reference
Mitochondrial energy metabolism of rat hippocampus after treatment with the antidepressants desipramine and fluoxetine
10.1016/j.neuropharm.2017.04.025 · 2017 · External reference
10.1371/journal.pone.0113662
10.1371/journal.pone.0113662 · External reference
10.1016/j.nurx.2005.12.003
10.1016/j.nurx.2005.12.003 · External reference
10.1016/j.schres.2019.09.007
10.1016/j.schres.2019.09.007 · External reference
10.1016/j.tips.2015.02.006
10.1016/j.tips.2015.02.006 · External reference
10.1016/s0039-6257(03)00004-3
10.1016/s0039-6257(03)00004-3 · External reference
An oldie but goodie: lithium in the treatment of bipolar disorder through neuroprotective and neurotrophic mechanisms
2017 · External reference
Lithium for schizophrenia: supporting evidence from a 12-year, nationwide health insurance database and from Akt1-deficient mouse and cellular models
10.1038/s41598-019-57340-8 · 2020 · External reference
10.1038/nrdp.2018.8
10.1038/nrdp.2018.8 · External reference
10.1111/j.1399-5618.2009.00714.x
10.1111/j.1399-5618.2009.00714.x · External reference
10.1038/tpj.2011.9
10.1038/tpj.2011.9 · External reference
10.1038/sj.npp.1300731
10.1038/sj.npp.1300731 · External reference
Gsk3 signalling and redox status in bipolar disorder: evidence from lithium efficacy
10.1155/2016/3030547 · 2016 · External reference
Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue
10.1111/j.1399-5618.2009.00729.x · 2009 · External reference
10.1007/s00232-017-9998-2
10.1007/s00232-017-9998-2 · External reference
Lithium and fluoxetine regulate the rate of phosphoinositide synthesis in neurons: a new view of their mechanisms of action in bipolar disorder
10.1038/s41398-018-0235-2 · 2018 · External reference
Role of protein kinase C in bipolar disorder: A review of the current literature
2017 · External reference
10.1016/j.neuropharm.2008.08.015
10.1016/j.neuropharm.2008.08.015 · External reference
10.1007/s00441-014-1806-z
10.1007/s00441-014-1806-z · External reference
10.1038/s41580-018-0052-8
10.1038/s41580-018-0052-8 · External reference
10.1016/j.yjmcc.2013.03.012
10.1016/j.yjmcc.2013.03.012 · External reference
Neuroprotective action of lithium in disorders of the central nervous system
2011 · External reference
10.1038/sj.mp.4002135
10.1038/sj.mp.4002135 · External reference
Lithium's gene expression profile, relevance to neuroprotection A cDNA microarray study
10.1007/s10571-013-9907-x · 2013 · External reference
Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity
10.1074/jbc.274.10.6039 · 1999 · External reference
Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects
10.1159/000314310 · 2010 · External reference
10.1038/sj.mp.4000494 · 1999 · Admitted local publication
10.1073/pnas.0307921101
10.1073/pnas.0307921101 · External reference
10.1038/mp.2017.16
10.1038/mp.2017.16 · External reference
Ant1 mutant mice bridge the mitochondrial and serotonergic dysfunctions in bipolar disorder
10.1038/s41380-018-0074-9 · 2018 · External reference
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
10.1038/mp.2015.4 · 2015 · External reference
10.1093/nar/gkv1003
10.1093/nar/gkv1003 · External reference
10.1093/nar/gkv1001
10.1093/nar/gkv1001 · External reference
10.1093/nar/gky1049
10.1093/nar/gky1049 · External reference
The gene ontology resource: 20 years and still going strong
10.1093/nar/gky1055 · 2019 · External reference
10.1093/database/bau012
10.1093/database/bau012 · External reference
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants
10.1093/nar/gkw943 · 2017 · External reference
10.1016/j.biopsych.2018.02.1175
10.1016/j.biopsych.2018.02.1175 · External reference
Analysis of a variable number tandem repeat polymorphism in the huntingtin interacting protein-1 related gene for anticipation in bipolar affective disorder
10.1016/j.pnpbp.2004.07.001 · 2004 · External reference
10.1093/nar/gkx1143
10.1093/nar/gkx1143 · External reference
Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder
10.1038/sj.mp.4001460 · 2004 · External reference
A molecular mechanism for the effect of lithium on development
10.1073/pnas.93.16.8455 · 1996 · External reference
Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis
2017 · External reference
10.1038/npp.2010.105
10.1038/npp.2010.105 · External reference
10.1016/j.biopsych.2009.04.015
10.1016/j.biopsych.2009.04.015 · External reference
Glycogen synthase kinase-3 in the etiology and treatment of mood disorders
2011 · External reference
10.1007/s12192-010-0226-6
10.1007/s12192-010-0226-6 · External reference
10.1128/mcb.25.5.1608-1619.2005
10.1128/mcb.25.5.1608-1619.2005 · External reference
10.1093/bib/bbx151
10.1093/bib/bbx151 · External reference
10.1038/mp.2016.89
10.1038/mp.2016.89 · External reference
10.1038/nm.3935
10.1038/nm.3935 · External reference
Neurons derived from patients with bipolar disorder divide into intrinsically different sub-populations of neurons, predicting the patients' responsiveness to lithium
10.1038/mp.2016.260 · 2018 · External reference
Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder
10.1038/nature15526 · 2015 · External reference
10.1016/j.mcn.2015.11.006
10.1016/j.mcn.2015.11.006 · External reference
10.1038/mp.2014.176
10.1038/mp.2014.176 · External reference
10.1038/tp.2014.12
10.1038/tp.2014.12 · External reference
10.1016/j.neuron.2018.10.007
10.1016/j.neuron.2018.10.007 · External reference
10.1038/s41398-019-0660-x
10.1038/s41398-019-0660-x · External reference
10.1038/nature25032
10.1038/nature25032 · External reference
10.1038/nature22330
10.1038/nature22330 · External reference
Cerebral organoids reveal early cortical maldevelopment in schizophrenia-computational anatomy and genomics, role of FGFR1
10.1038/s41398-017-0054-x · 2017 · External reference
Brain organoids: advances, applications and challenges
10.1242/dev.166074 · 2019 · External reference
10.1038/nrn3229
10.1038/nrn3229 · External reference
10.1038/nrdp.2016.80
10.1038/nrdp.2016.80 · External reference
10.1016/j.isci.2019.08.057
10.1016/j.isci.2019.08.057 · External reference
BraInMap elucidates the macromolecular connectivity landscape of mammalian brain
2020 · External reference
10.1016/j.neuroscience.2018.12.045
10.1016/j.neuroscience.2018.12.045 · External reference
A drug discovery platform to identify compounds that inhibit EGFR triple mutants
2020 · External reference
10.1038/nmeth.2895
10.1038/nmeth.2895 · External reference
CRISPR-based genetic interaction maps inform therapeutic strategies in cancer
10.21037/tcr.2018.01.02 · 2018 · External reference
10.1038/mp.2013.170
10.1038/mp.2013.170 · External reference
Integrative transcriptomics reveals sexually dimorphic control of the cholinergic/neurokine interface in schizophrenia and bipolar disorder
10.1016/j.celrep.2019.09.017 · 2019 · External reference
10.1371/journal.pone.0023881
10.1371/journal.pone.0023881 · External reference
Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression
10.1038/mp.2013.58 · 2014 · External reference
MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function
10.1073/pnas.1113793109 · 2012 · External reference
Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder
10.1093/hmg/ddr416 · 2011 · External reference
10.1016/j.neuro.2011.11.008
10.1016/j.neuro.2011.11.008 · External reference
10.1039/c2mb25118c
10.1039/c2mb25118c · External reference
Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders
10.1080/14789450.2018.1444483 · 2018 · External reference
10.1186/s13073-017-0467-4
10.1186/s13073-017-0467-4 · External reference
10.1016/j.jmb.2006.06.024
10.1016/j.jmb.2006.06.024 · External reference
10.1038/nrg3552
10.1038/nrg3552 · External reference
Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes
10.1186/1471-2105-13-182 · 2012 · External reference
PyMINEr finds gene and autocrine-paracrine networks from human islet scRNA-Seq
10.1016/j.celrep.2019.01.063 · 2019 · External reference
10.18632/oncotarget.19481
10.18632/oncotarget.19481 · External reference
10.1038/s41588-018-0129-5
10.1038/s41588-018-0129-5 · External reference
10.1038/s41593-017-0029-5
10.1038/s41593-017-0029-5 · External reference
Interactome-transcriptome analysis discovers signatures complementary to GWAS loci of type 2 diabetes
10.1038/srep35228 · 2016 · External reference
10.1016/j.bpsc.2017.11.007
10.1016/j.bpsc.2017.11.007 · External reference
Using machine learning in psychiatry: the need to establish a framework that nurtures trustworthiness
2020 · External reference
Artificial intelligence for mental health and mental illnesses: an overview
10.1007/s11920-019-1094-0 · 2019 · External reference
10.1038/s41573-019-0024-5
10.1038/s41573-019-0024-5 · External reference
10.1021/acs.chemrev.8b00728
10.1021/acs.chemrev.8b00728 · External reference
10.1016/j.ebiom.2019.08.027
10.1016/j.ebiom.2019.08.027 · External reference
DeepCOP: deep learning-based approach to predict gene regulating effects of small molecules
10.1093/bioinformatics/btz645 · 2020 · External reference
How artificial intelligence is changing drug discovery
10.1038/d41586-018-05267-x · 2018 · External reference
Right drug-right patient-right time: personalized medicine coalition
10.1111/j.1752-8062.2008.00003.x · 2008 · External reference
How effective are common medications: a perspective based on meta-analyses of major drugs
10.1186/s12916-015-0494-1 · 2015 · External reference
Pharmacogenomics: the genetics of variable drug responses
10.1161/circulationaha.109.914820 · 2011 · External reference
10.1093/bib/bby051
10.1093/bib/bby051 · External reference
Twenty years with personalized medicine: past, present, and future of individualized pharmacotherapy
10.1634/theoncologist.2019-0054 · 2019 · External reference
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV
10.1200/jco.2013.49.9020 · 2014 · External reference
Systems biology approaches toward understanding primary mitochondrial diseases
10.3389/fgene.2019.00019 · 2019 · External reference
Overview of systems biology and omics technologies
10.2174/0929867323666160926150617 · 2016 · External reference
10.1016/j.cell.2014.02.012
10.1016/j.cell.2014.02.012 · External reference
10.1016/s1474-4422(11)70155-7
10.1016/s1474-4422(11)70155-7 · External reference
Systems biological approach on neurological disorders: a novel molecular connectivity to aging and psychiatric diseases
10.1186/1752-0509-5-6 · 2011 · External reference
Identification of biomarkers in neuropsychiatric disorders based on systems biology and epigenetics
10.3389/fgene.2019.00985 · 2019 · External reference
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
10.1067/mcp.2001.113989 · 2001 · External reference
The new field of 'precision psychiatry'
10.1186/s12916-017-0849-x · 2017 · External reference
Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis
10.1016/j.jpsychires.2009.04.010 · 2009 · External reference
10.1159/000441457
10.1159/000441457 · External reference
10.1017/s0033291716000957
10.1017/s0033291716000957 · External reference
10.1126/science.1069492
10.1126/science.1069492 · External reference
The application of mHealth to mental health: opportunities and challenges
10.1016/s2215-0366(15)00268-0 · 2015 · External reference
10.1016/j.jacbts.2016.11.010
10.1016/j.jacbts.2016.11.010 · External reference
10.1002/humu.22851
10.1002/humu.22851 · External reference
